|
|
Office Locations:
|
801 W. Baltimore St, Suite 500
Baltimore , MD 21201
Phone: 667-260-5785
| |
|
|
|
|
|
|
Life Sciences & Healthcare
|
|
|
|
The Illumina Accelerator Program is the world's first business accelerator focused on creating an innovation ecosystem for the genomics industry. Its goal is to speed the time to market and lower the barriers to entry for start-ups and early stage companies working on scientifically and commercially promising next-generation sequencing applications. Through the accelerator's six-month program, Illumina will provide participants with technology/business guidance, $100,000 in support, and access to lab space in close proximity to the company's R&D facilities in San Francisco's Mission Bay. Initial partners include technology investor Yuri Milner, who will offer each participating company $100,000 in exchange for convertible notes, and Silicon Valley Bank, which intends to provide banking services and credit to each participating company. Illumina will take a 10% common stock in startups that participate in the program. The program's revenue was $3.3 billion in 2018 and employs 7,300.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
